Tag: bioscience

British artificial intelligence start-up BenevolentAI has bagged $115 million from investors, lifting its pre-money valuation to $2 billion. The London-based firm, which is focused on the pharmaceutical industry, said the latest round of funding will help it scale drug development and its AI platform. The company currently has more than 20 drug programs. It said…